NEW YORK, May 3 - Schering said today it hopes to close the sale of its 24-percent stake in Aventis' CropScience unit to Bayer between May 20 and June 5.

Bayer agreed to acquire the CropScience business from Aventis and Schering for7.25 billion, or roughly $6.63 billion, in a deal that will propel Bayer to the No. 2 spot in the agrochemicals sector.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.